Element Capital Management’s Edwards Lifesciences EW Stock Holding History

Element Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,369	Closed	-$2.78M	–	57
2025 Q1	$2.78M	Buy	+38,369	New	+$2.75M	0.69%	24
2023 Q4	–	Sell	-50,322	Closed	-$3.49M	–	84
2023 Q3	$3.49M	Sell	50,322 -29,969	-37%	-$2.41M	0.31%	89
2023 Q2	$7.57M	Buy	80,291 +4,293	+6%	+$373K	0.51%	47
2023 Q1	$6.29M	Buy	+75,998	New	+$5.97M	0.47%	53
2022 Q4	–	Sell	-6,914	Closed	-$571K	–	68
2022 Q3	$571K	Hold	6,914	–	–	0.27%	75
2022 Q2	$657K	Buy	6,914 +2,305	+50%	+$239K	0.33%	64
2022 Q1	$543K	Buy	+4,609	New	+$517K	0.27%	73
2019 Q4	–	Sell	-44,976	Closed	-$3.3M	–	100
2019 Q3	$3.3M	Buy	+44,976	New	+$3.16M	0.29%	82
2015 Q3	–	Sell	-6,600	Closed	-$157K	–	173
2015 Q2	$157K	Buy	+6,600	New	+$149K	0.06%	158

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Element Capital Management's EW Position: Q2 2025 in Review

Element Capital Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 38,369 shares — an estimated $2.78M sold.

Element Capital Management first reported a position in EW in Q2 2015 and held it in 9 quarters. The position peaked at $7.57M in Q2 2023. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

Element Capital Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
Element Capital Management sold 38,369 Edwards Lifesciences shares in Q2 2025, an estimated $2.78M.
Element Capital Management first reported a position in Edwards Lifesciences in Q2 2015 and held it in 9 quarters.
Element Capital Management's Edwards Lifesciences position peaked at $7.57M in Q2 2023.
1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Element Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.